In a stark reflection of the challenges facing the biotech sector, 10X Genomics Inc (NASDAQ:TXG) stock has tumbled to a 52-week low, touching down at $11.89. According to InvestingPro data, technical ...

Wall Street analysts expect 10x Genomics (TXG) to post quarterly loss of $0.32 per share in its upcoming report, which indicates a year-over-year increase of 22%. Revenues are expected to be $158.14 ...

CircleDNA powers blockchain-based identity verification with Humanity Protocol, valued at US $1.1bn after latest fundraisePrenetics invests $1.5M ...

Patrick Tan to receive Genome Valley Excellence Award at BioAsia for pioneering work in precision medicine and cancer ...

Hyderabad: BioAsia, Asia's largest annual global biotechnology and life sciences forum, announced that the prestigious Genome ...

Evolution is traditionally associated with a process of increasing complexity and gaining new genes. However, the explosion of the genomic era shows that gene loss and simplification is a much more ...

Owing to his contributions to these fields, the state government will felicitate Prof. Patrick Tan, executive director of ...

Northwestern Medicine scientists have discovered new details about how the human genome produces instructions for creating ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

Bruker shares fell by 2.5%, Illumina by 3.3%, Quanterix by 2.8%, Bio-Techne by 5%, 10X Genomics by 8.8%, and Qiagen by 3.5%. Analysts have noted that this move by the NIH could have a material impact ...

The number of area high schools partnering with HudsonAlpha Wiregrass in a peanut breeding program jumped to 10 with the ...